Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.22
+0.05 (0.97%)
Jan 22, 2025, 11:35 AM EST - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $198.43 million as of January 22, 2025. Its market cap has decreased by -26.95% in one year.
Market Cap
198.43M
Enterprise Value
136.57M
1-Year Change
-26.95%
Ranking
Category
Stock Price
$5.22
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $198.43M, an increase of 0.50%. That is a compound annual growth rate of 0.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 200.71M | 32.00% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |